Thoracic Spine and Shoulder Kinematics and Muscle Activation in Rock Climbers With Shoulder Pain

May 19, 2025 updated by: Yin-Liang Lin, National Yang Ming Chiao Tung University

Kinematics and Muscle Activation of Thoracic Spine and Shoulder in Rock Climbers With Shoulder Pain

Background and Purpose: Rock climbing has been a popular sport in recent years. Rock climbing includes various open-chain and closed-chain arm movements. Overhead reaching and pull-up are the basic rock climbing elements heavily involving upper extremities. Different inclination of the wall and terrain also demand sufficient range of motion and strength of the trunk. Generally overhead reaching and arm elevation may have similar shoulder kinematics, including scapular upward rotation, posterior tilt and external rotation. Arm elevation usually is accompanied with thoracic extension and unilateral lateral flexion and rotation. During pull-up, the scapula rotates downward and externally and tilts anterior. The prevalence of shoulder injuries are about 17%, the second most common among rock climbing injuries. In the shoulder injuries, shoulder labrum lesions and shoulder impingement are the most common. Previous studies have shown that individuals with shoulder impingement syndrome have shown decreased upward and externally rotation during arm elevation, and have limited thoracic extension range of motion and greater kyphotic posture. However, a previous study found no difference in the scapular kinematics and scapular muscle activation during pull-up in rock climbers with shoulder pain and healthy climbers. The non-significant finding may be due to that the pure pull-up may not mimic climbing tasks, in which the shoulder and trunk need to adapt different inclination of the wall. Therefore, the purpose of this study is to investigate the kinematics and muscle activation of the thoracic spine and shoulder in rock climbers with shoulder pain during climbing tasks with different reaching angles. Methods: Thirty sport climbers with shoulder pain and 30 healthy climbers matched with gender, age, and dominant hand will be recruited in this study. Testing tasks will include arm elevation in the scapular plane, overhead reaching to the target 15° backward to the frontal plane, pull-up with overhead reaching forward and backward. Thoracic and shoulder kinematics will be collected using an electromagnetic tracking system. The upper trapezius, lower trapezius, serratus anterior, latissimus dorsi, and erector spinae were collected with surface electromyography (EMG). A two-way mixed ANOVA will be used to determine differences between groups in the kinematics and EMG measures at the different arm elevation angles for the testing tasks.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
37

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Taiwan
      • Taipei, Taiwan, 112
        • National Yang Ming Chiao Tung University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Rock climbers with and without shoulder pain

Description

Inclusion Criteria of Patients with Shoulder Pain:

  1. Ages ranges from 18-40 years old
  2. At least one year of experience of sport climbing
  3. Sport Climbing frequency ≥ 6 hours per week in the last one month
  4. Shoulder pain ≥ 1 month
  5. Minimum of 3/10 on the numerical rating scale (NRS) in the last one month

Inclusion Criteria of Healthy Subjects in the control group:

  1. Ages ranges from 18-40 years old
  2. Gender, age, dominant hand and experience matching to shoulder pain climbers group
  3. At least one year of experience of sport climbing
  4. Sport Climbing at least 6 hours per week in the last one month
  5. No history of shoulder pain in the last six months

Exclusion Criteria of Patients with Shoulder Pain and All Healthy Subjects

  1. History of upper limb surgery or fracture
  2. History of shoulder dislocation
  3. History of neck pain, back pain, or elbow injuries in the last one year
  4. Wrist or finger pain during sport climbing > 3/10 on the numerical rating scale (NRS)
  5. Shoulder pain during pull-up > shoulder pain during sport climbing
  6. Intensive exercise within 12 hours or any delay onset muscle soreness
  7. Systemic autoimmune disease
  8. Cancer
  9. Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
rock climbers (healthy group)
Climbers without shoulder pain
Device: Electromagnetic tracking system, surface electromyography
arm elevation in the scapular plane, overhead reaching to the target 15° backward to the frontal plane, pull-up with overhead reaching forward and backward.
rock climbers (shoulder pain group)
Climbers with shoulder pain
Device: Electromagnetic tracking system, surface electromyography
arm elevation in the scapular plane, overhead reaching to the target 15° backward to the frontal plane, pull-up with overhead reaching forward and backward.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Shoulder kinematics during arm elevation
Time Frame: Immediately during the experiment
Scapular kinematics, including anterior/posterior tilt, upward/downward rotation, and internal/external rotation in scapular plane elevation at 30°, 60°, 90°, and 120°, and will be described with degree (°).
Immediately during the experiment
Scapular muscles activation during arm elevation
Time Frame: Immediately during the experiment
The root mean square of electromyography (EMG) data of the upper trapezius, lower trapezius, serratus anterior, and latissimus dorsi will be normalized by the maximum voluntary contraction amplitude (percentage of maximal voluntary contraction, %) and calculated over three 30° increments of motion during arm elevation from 30° to 120°, including 30° - 60°, 60° - 90°, and 90° - 120°.
Immediately during the experiment
Thoracic kinematics during arm elevation
Time Frame: Immediately during the experiment
Thoracic kinematics, including flexion, extension, side flexion and rotation in arm elevation at 30°, 60°, 90°, and 120°, and will be described with degree (°).
Immediately during the experiment
Shoulder kinematics during pull-up with overhead reaching forward and backward
Time Frame: Immediately during the experiment
Scapular kinematics, including anterior/posterior tilt, upward/downward rotation, and internal/external rotation, and will be described with degree (°).
Immediately during the experiment
Thoracic kinematics during pull-up with overhead reaching forward and backward
Time Frame: Immediately during the experiment
Thoracic kinematics, including flexion, extension, side flexion and rotation
Immediately during the experiment
Trunk muscle activation during arm elevation
Time Frame: Immediately during the experiment
The root mean square of electromyography (EMG) data of the erector spinae will be normalized by the maximum voluntary contraction amplitude (percentage of maximal voluntary contraction, %) and calculated over three 30° increments of motion during arm elevation from 30° to 120°, including 30° - 60°, 60° - 90°, and 90° - 120°.
Immediately during the experiment
Scapular muscles activation during pull-up with overhead reaching forward and backward
Time Frame: Immediately during the experiment
The root mean square of electromyography (EMG) data of the upper trapezius, lower trapezius, serratus anterior, and latissimus dorsi will be normalized by the maximum voluntary contraction amplitude (percentage of maximal voluntary contraction, %)
Immediately during the experiment
Trunk muscle activation during overhead reaching forward and backward.
Time Frame: Immediately during the experiment
The root mean square of electromyography (EMG) data of the erector spinae will be normalized by the maximum voluntary contraction amplitude (percentage of maximal voluntary contraction, %)
Immediately during the experiment

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Thoracic mobility
Time Frame: Immediately during the experiment
Range of motion of thoracic spine, described with degree (°).
Immediately during the experiment
Thoracic kyphosis angle
Time Frame: Immediately during the experiment
measured by inclinometers, described with degree (°).
Immediately during the experiment
Muscle length of pectoralis major
Time Frame: Immediately during the experiment
In a supine position with hands behind the head. A positive (+) indicates muscle tightness, when the elbows cannot touch the testing surface.
Immediately during the experiment
Muscle length of pectoralis minor
Time Frame: Immediately during the experiment
In a supine position, the distance between acromion and testing surface, described with cm.
Immediately during the experiment
Muscle length of latissimus dorsi
Time Frame: Immediately during the experiment
shoulder flexion range of motion in a hook-lying position, described with degree (°)
Immediately during the experiment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
National Yang Ming Chiao Tung University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: YIN-LIANG LIN, National Yang Ming Chiao Tung University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 11, 2023

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 28, 2024

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
November 13, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
July 11, 2023

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
July 11, 2023

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
July 18, 2023

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
May 22, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
May 19, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
May 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • NYCU112095AE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings